Because, in our previous studies, we demonstrated that iPA treatment affected the activity of IKKβ‐NF‐κB pathway [36], the present study tested the phosphorylation state of IKKβ/NFKB pathway in GBM cells treated with iPA. The gene discussed is NFKB1; the disease is glioblastoma.